Humana (NYSE:HUM) Trading 8.6% Higher – Here’s What Happened

Humana Inc. (NYSE:HUM) traded up 8.6% during trading on Monday . The company traded as high as $331.87 and last traded at $331.5560. 254,686 shares traded hands during trading, a decline of 87% from the average session volume of 1,920,737 shares. The stock had previously closed at $305.42.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Barclays increased their price objective on Humana from $180.00 to $344.00 and gave the company an “equal weight” rating in a report on Tuesday, May 26th. Cantor Fitzgerald started coverage on Humana in a research note on Wednesday, May 20th. They set an “overweight” rating for the company. Zacks Research upgraded Humana from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 13th. Deutsche Bank Aktiengesellschaft downgraded Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, May 20th. Finally, Oppenheimer upgraded Humana from an “outperform” rating to an “outperform” rating in a research note on Wednesday, May 20th. Nine investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat, Humana currently has a consensus rating of “Hold” and a consensus price target of $272.65.

Humana Stock Performance

The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The stock has a fifty day moving average price of $231.96 and a 200-day moving average price of $228.98. The firm has a market capitalization of $39.64 billion, a price-to-earnings ratio of 35.34, a PEG ratio of 2.21 and a beta of 0.76.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.Humana’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, analysts anticipate that Humana Inc. will post 9.01 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.1%. Humana’s payout ratio is currently 37.86%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Illinois Municipal Retirement Fund lifted its stake in Humana by 9.6% in the third quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock worth $12,920,000 after purchasing an additional 4,351 shares during the last quarter. National Pension Service lifted its stake in Humana by 2.8% in the third quarter. National Pension Service now owns 189,601 shares of the insurance provider’s stock worth $49,328,000 after purchasing an additional 5,150 shares during the last quarter. Long Focus Capital Management LLC bought a new stake in Humana in the third quarter worth $34,212,000. Tejara Capital Ltd bought a new stake in Humana in the third quarter worth $1,873,000. Finally, AMG National Trust Bank lifted its stake in Humana by 106.5% in the third quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock worth $4,411,000 after purchasing an additional 8,744 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.